These 49 Countries Are Spending the Most on Coronavirus


It’s hard to measure the price of a global pandemic. If we were to try, it might be some great concoction of sky-high unemployment rates, ruined investment portfolios, businesses who may never open their doors again, and of course, the loss of human life that can never be recovered. 

While we can’t truly determine what the coronavirus has cost us as human beings, we can look at what it’s costing countries around the world. Using data from the U.S. News and World Report, International Monetary Fund, World Bank and United Nations, GOBankingRates found the 49 countries that are spending the most on the coronavirus outbreak. As of early May, these countries all had at least 5,000 confirmed cases of COVID-19 and were taking fiscal action to try to stem the damage. 

The study is ranked from countries spending the least on coronavirus to countries spending the most — not in Read More

Lloyd’s of London to pay up to $4.3 bln in coronavirus claims


By Carolyn Cohn

LONDON (Reuters) – Lloyd’s of London is likely to pay out $3.0-4.3 billion in claims related to the coronavirus pandemic and underwriting and investment losses for the global non-life insurance sector could reach a record $203 billion, Lloyd’s said on Thursday.

Insurers across the globe have suffered losses from the virus, which has locked down economies, bringing businesses, events and travel to a halt.

Reinsurer Swiss Re <SRENH.S> said last month it took a hit of $476 million for anticipated and actual pandemic-related claims, whie German insurer Allianz <ALVG.DE> this week reported a nearly 30% drop in first-quarter profit.

In a double blow, insurers have also lost money due to falling markets, slashing the investments they use to pay out claims.

“I don’t think anyone in our industry has ever seen both happen at once,” Lloyd’s Chief Executive John Neal told Reuters.

Insured losses are likely to

Read More

Are Biotech ETFs in Trouble as Coronavirus Dims Guidance?


The coronavirus has infected more than three million people across the globe. The death toll has surpassed 269,000 worldwide, according to Johns Hopkins University. In such a scenario, the desperation for a vaccine or treatment is rising by the hour. The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. From positive news related to Gilead Sciences’ remdesivir to progress in development of cell therapies for the treatment of COVID-19, these developments have kept the sector surging.

Although the coronavirus outbreak seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite delivering impressive results, most of the following biotech companies have been seeing declining share prices since the earnings releases largely due to coronavirus-hit outlooks. Let’s take a look at some big biotechnological earnings releases to see if these will impact

Read More

Nebraska Coronavirus Relief Programs


 Nebraska has one of the lowest coronavirus infection rates in the nation, and the governor has not issued a blanket stay-at-home order as many other governors have done. Nevertheless, the pandemic has affected people and small businesses in the Cornhusker State. By the end of April, Nebraska had more than 2,700 cases and more than 50 fatalities because of COVID-19. Unemployment is soaring: There have been 83,000 initial unemployment claims in five weeks, roughly the number of applications the state saw in the last two years combined. By mid-April, the jobless rate was 4.2%. The good news is that residents and small businesses affected by the coronavirus and its economic fallout can avail themselves of state and federal help as the crisis continues. Here is an overview of the programs and resources available to Nebraskans.

Nebraska Coronavirus Relief for Individuals

The state has both new and existing programs available

Read More